These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 29329650)
21. Design, synthesis and biological evaluation of novel nitric oxide-donating protoberberine derivatives as antitumor agents. Chen J; Wang T; Xu S; Lin A; Yao H; Xie W; Zhu Z; Xu J Eur J Med Chem; 2017 May; 132():173-183. PubMed ID: 28359045 [TBL] [Abstract][Full Text] [Related]
22. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity. Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661 [No Abstract] [Full Text] [Related]
23. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment. Bao X; Gao M; Xu H; Liu KX; Zhang CH; Jiang N; Chu QC; Guan X; Tian Y Drug Dev Ind Pharm; 2015; 41(7):1193-203. PubMed ID: 25026246 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluations of N'-substituted methylene-4-(quinoline-4-amino) benzoylhydrazides as potential anti-hepatoma agents. Li B; Zhu F; He F; Huang Q; Liu X; Wu T; Zhao T; Qiu Y; Wu Z; Xue Y; Fang M Bioorg Chem; 2020 Mar; 96():103592. PubMed ID: 32044517 [TBL] [Abstract][Full Text] [Related]
25. Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking. Eldehna WM; Fares M; Ibrahim HS; Aly MH; Zada S; Ali MM; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA Eur J Med Chem; 2015 Jul; 100():89-97. PubMed ID: 26071861 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and antitumor activity of oleanolic acid derivatives. Meng YQ; Kuai ZY; Zhan SW; Li CL; Chen HR J Asian Nat Prod Res; 2019 Jul; 21(7):633-651. PubMed ID: 29733221 [TBL] [Abstract][Full Text] [Related]
27. YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acid. Xu G; Wang J; Wu F; Wang N; Zhou W; Wang Q; Pan W; Ao G; Yang J Oncotarget; 2016 Aug; 7(32):52150-52165. PubMed ID: 27437776 [TBL] [Abstract][Full Text] [Related]
28. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB. Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of oleanolic acid derivatives as antitumor agents. Chen L; Wu JB; Lei F; Qian S; Hai L; Wu Y J Asian Nat Prod Res; 2012; 14(4):355-63. PubMed ID: 22375874 [TBL] [Abstract][Full Text] [Related]
30. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies. Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol. Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor activity evaluation of novel oleanolic acid derivatives. Meng YQ; Zhao YW; Kuai ZY; Liu LW; Li W J Asian Nat Prod Res; 2017 Oct; 19(10):1000-1010. PubMed ID: 28140665 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents. Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of oleanolic acid dimers linked at C-28 and evaluation of anti-tumor activity. Cheng KG; Su CH; Yang LD; Liu J; Chen ZF Eur J Med Chem; 2015 Jan; 89():480-9. PubMed ID: 25462260 [TBL] [Abstract][Full Text] [Related]
36. Synthesis of Oleanolic Acid Analogues and Their Cytotoxic Effects on 3T3 Cell Line. Tuncay S; Senol H; Guler EM; Ocal N; Secen H; Kocyigit A; Topcu G Med Chem; 2018; 14(6):617-625. PubMed ID: 29473521 [TBL] [Abstract][Full Text] [Related]
37. JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways. Ren Z; Kar S; Wang Z; Wang M; Saavedra JE; Carr BI J Cell Physiol; 2003 Dec; 197(3):426-34. PubMed ID: 14566972 [TBL] [Abstract][Full Text] [Related]
38. Design and Synthesis of New Anticancer Glycyrrhetinic Acids and Oleanolic Acids. Wang R; Zheng QX; Wang W; Feng L; Li HJ; Huai QY Biol Pharm Bull; 2017; 40(5):703-710. PubMed ID: 28458357 [TBL] [Abstract][Full Text] [Related]
39. HCV protease inhibitory, cytotoxic and apoptosis-inducing effects of oleanolic acid derivatives. Ma CM; Wu XH; Masao H; Wang XJ; Kano Y J Pharm Pharm Sci; 2009; 12(3):243-8. PubMed ID: 20067701 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives. Hao J; Liu J; Wen X; Sun H Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]